Lv4
460 积分 2024-07-01 加入
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
6小时前
待确认
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
6小时前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
18天前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
18天前
已完结
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
1个月前
已完结
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
1个月前
已完结
Acute kidney injury from SGLT2 inhibitors: potential mechanisms
1个月前
已完结
Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes
1个月前
已完结
Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 ( SGLT2 ) inhibitor, in subjects with renal impairment
1个月前
已完结
皖公网安备34019202002308
